News from Moleac

Apr 28, 2014, 03:00 ET

Moleac Appoints Elmar Schnee as Non-Executive Chairman

Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive...

Jun 21, 2013, 12:55 ET

Un traitement issu de la Médecine Traditionnelle Chinoise améliore les chances de récupération après un Accident Vasculaire Cérébral (AVC)

- La société savante CHIMES (cf. dernière page) a mené le premier grand essai clinique évaluant un médicament...

Jun 20, 2013, 10:50 ET

Stroke Treatment Based on Traditional Chinese Medicine Increases Chances of Recovery

NeuroAiD, a stroke treatment based on Traditional Chinese Medicine, increases the odds of achieving a better functional outcome, according to...

Mar 19, 2013, 23:19 ET

NeuroAiD(TM), a Stroke Treatment Based on Traditional Chinese Medicine, More than Doubles the Chances of Achieving Independence after Stroke

Authors of a medical paper published in this month's Cerebrovascular Diseases journal found that NeuroAiD™, developed by Moleac,...

Nov 25, 2011, 10:00 ET

Moleac Announces the Launch of NurAiD II in France, a "Recovery Stimulator" Marketed as a Natural Food Supplement

Biopharmaceutical Company Moleac has announced the launch in France and Belgium of NurAiD II. NurAiD II is a natural health supplement engineered...

Nov 25, 2011, 04:30 ET

Moleac annonce le lancement de NurAiD II en France et en Belgique, un complément alimentaire naturel « activateur de récupération »

Moleac, société biopharmaceutique, annonce le lancement de son supplément alimentaire NurAiD II en France. Ce produit,...

Jun 27, 2011, 22:00 ET

Moleac Announces the Beneficial Effect of NeuroAiD (TM) (MLC 901) in Protecting the Brain Against Global Ischemia

 In June 2011, "Neuropharmacology" published a paper establishing NeuroAiD's reparative effects on global cerebral ischemia. Global cerebral...

Mar 13, 2010, 08:00 ET

Moleac Receives BioSpectrum Asia Emerging Company of the Year 2010 Award

Moleac Pte Ltd has been granted the Emerging Company of the Year 2010 Award by BioSpectrum, the leading integrated media platform for the Life...

Feb 11, 2010, 07:00 ET

Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD

The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting...

Apr 21, 2009, 10:00 ET

Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards

Moleac has been named the Singapore Entrepreneurial Company of the Year, by Frost & Sullivan. This award recognizes companies that have pushed...

Apr 03, 2008, 01:00 ET

Moleac Announces Series A Investment

SINGAPORE, April 3, 2008 /Xinhua-PRNewswire/ -- Singapore-based Moleac announced that it has raised US$3.5 million. This Series A investment...

Mar 06, 2008, 00:00 ET

Moleac Launches NeuroAid10(TM) in the United States

SINGAPORE, March 6 /Xinhua-PRNewswire/ -- Singapore-based Moleac today launched a new product called NeuroAid10(TM) in the US market to support...

Sep 27, 2007, 01:00 ET

International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery

SINGAPORE, Sept. 27 /Xinhua-PRNewswire/ -- NeuroAid(TM) is the first natural compound to be studied in a large clinical trial focused on stroke...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review